← Back to contracts

Developing a kinase inhibitor drug to treat spinal cord injury

US National Institute of Neurological Disorders and Stroke grant open #nih-3UH3NS124630-04S1

Summary

ABSTRACT Spinal cord injury (SCI) is a devastating condition with life-long consequences that include paralysis. Central nervous system (CNS) axons typically fail to regenerate, leading to irreversible losses of neuronal connectivity and associated functions after injury. SCI is now estimated to cost the nation’s healthcare system around $40.5 billion annually (CDC). People living with paralysis are often unable to afford health insurance that adequately covers the associated complex secondary or chronic conditions, which places tremendous economic burden and psychological suffering on them an

Developing a kinase inhibitor drug to trea…
Onboard